BiotechTube
Home/Adagene/Peggy S. Berry
PS

Peggy S. Berry

President, Head of Global Regulatory Affairs & Quality

Adagene

Therapeutic Areas

OncologyImmuno-Oncology

Adagene Pipeline

DrugIndicationPhase
ADG126Advanced/Metastatic Solid TumorsPhase 1b/2
ADG206Advanced/Metastatic Solid TumorsPhase 1
ADG116Advanced/Metastatic Solid TumorsPhase 1
ADG106Advanced/Metastatic Solid Tumors & Non-Hodgkin LymphomaPhase 1
ADG125Solid TumorsPreclinical
ADG153Solid TumorsPreclinical

Leadership Team at Adagene

PL
Peter Luo
Co-Founder, Chief Executive Officer, Chairman of the Board
XY
Xiaodong Yang
Co-Founder, Chief Scientific Officer
TX
Tian Xie
Co-Founder, Chief Technology Officer
SS
Shan Song
Chief Financial Officer
AS
Alfred Sandrock, Jr.
Independent Director
LB
Lars Birgerson
Independent Director
SW
Stephanie Wong
Vice President, Clinical Development
LC
Lei Chen
Vice President, Biologics Discovery
YF
Yan Feng
Vice President, Translational Science
View full Adagene profile